Movatterモバイル変換

[0]ホーム
URL:

Jump to content
WikipediaThe Free Encyclopedia
Search

MGS-0039

From Wikipedia, the free encyclopedia
Chemical compound
Pharmaceutical compound
MGS-0039
Clinical data
ATC code
  • None
Legal status
Legal status
  • In general: non-regulated
Identifiers
  • (1R,2R,3R,5R,6R)-2-amino-3-(3,4-dichlorobenzyloxy)-6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic acid
CAS Number
PubChemCID
IUPHAR/BPS
ChemSpider
UNII
CompTox Dashboard(EPA)
Chemical and physical data
FormulaC15H14Cl2NO5
Molar mass359.18 g·mol−1
3D model (JSmol)
  • F[C@@]2(C(=O)O)[C@H]3[C@@](C(=O)O)(N)[C@H](OCc1ccc(Cl)c(Cl)c1)C[C@@H]23
  • InChI=1S/C15H14Cl2FNO5/c16-8-2-1-6(3-9(8)17)5-24-10-4-7-11(14(7,18)12(20)21)15(10,19)13(22)23/h1-3,7,10-11H,4-5,19H2,(H,20,21)(H,22,23)/t7-,10-,11+,14-,15+/m1/s1
  • Key:LFAGGDAZZKUVKO-JAGWWQSPSA-N

MGS-0039 is adrug that is used inneuroscientific research, which acts as apotent andselectiveantagonist forgroup II of themetabotropic glutamate receptors (mGluR2/3).[1][2] It producesantidepressant andanxiolytic effects in animal studies,[3][4][5][6] and has been shown to boost release ofdopamine andserotonin in specific brain areas.[7][8] Research has suggested this may occur through a similar mechanism as that suggested for the similarly glutamatergic drugketamine.[9][10]

References

[edit]
  1. ^Chaki S, Yoshikawa R, Hirota S, Shimazaki T, Maeda M, Kawashima N, et al. (March 2004). "MGS0039: a potent and selective group II metabotropic glutamate receptor antagonist with antidepressant-like activity".Neuropharmacology.46 (4):457–67.doi:10.1016/j.neuropharm.2003.10.009.PMID 14975669.S2CID 40533560.
  2. ^Nakazato A, Sakagami K, Yasuhara A, Ohta H, Yoshikawa R, Itoh M, et al. (August 2004). "Synthesis, in vitro pharmacology, structure-activity relationships, and pharmacokinetics of 3-alkoxy-2-amino-6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivatives as potent and selective group II metabotropic glutamate receptor antagonists".Journal of Medicinal Chemistry.47 (18):4570–87.doi:10.1021/jm0400294.PMID 15317467.
  3. ^Shimazaki T, Iijima M, Chaki S (October 2004). "Anxiolytic-like activity of MGS0039, a potent group II metabotropic glutamate receptor antagonist, in a marble-burying behavior test".European Journal of Pharmacology.501 (1–3):121–5.doi:10.1016/j.ejphar.2004.08.016.PMID 15464070.
  4. ^Yasuhara A, Nakamura M, Sakagami K, Shimazaki T, Yoshikawa R, Chaki S, et al. (June 2006). "Prodrugs of 3-(3,4-dichlorobenzyloxy)-2-amino-6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (MGS0039): a potent and orally active group II mGluR antagonist with antidepressant-like potential".Bioorganic & Medicinal Chemistry.14 (12):4193–207.doi:10.1016/j.bmc.2006.01.060.PMID 16487713.
  5. ^Yoshimizu T, Shimazaki T, Ito A, Chaki S (July 2006). "An mGluR2/3 antagonist, MGS0039, exerts antidepressant and anxiolytic effects in behavioral models in rats".Psychopharmacology.186 (4):587–93.doi:10.1007/s00213-006-0390-7.PMID 16612616.S2CID 7801709.
  6. ^Stachowicz K, Wierońska J, Domin H, Chaki S, Pilc A (2011). "Anxiolytic-like activity of MGS0039, a selective group II mGlu receptor antagonist, is serotonin- and GABA-dependent".Pharmacological Reports.63 (4):880–7.doi:10.1016/S1734-1140(11)70603-X.PMID 22001975.
  7. ^Kawashima N, Karasawa J, Shimazaki T, Chaki S, Okuyama S, Yasuhara A, Nakazato A (April 2005). "Neuropharmacological profiles of antagonists of group II metabotropic glutamate receptors".Neuroscience Letters.378 (3):131–4.doi:10.1016/j.neulet.2004.12.021.PMID 15781145.S2CID 26509964.
  8. ^Karasawa J, Yoshimizu T, Chaki S (January 2006). "A metabotropic glutamate 2/3 receptor antagonist, MGS0039, increases extracellular dopamine levels in the nucleus accumbens shell".Neuroscience Letters.393 (2–3):127–30.doi:10.1016/j.neulet.2005.09.058.PMID 16233956.S2CID 20736438.
  9. ^Pałucha-Poniewiera A, Wierońska JM, Brański P, Stachowicz K, Chaki S, Pilc A (December 2010)."On the mechanism of the antidepressant-like action of group II mGlu receptor antagonist, MGS0039".Psychopharmacology.212 (4):523–35.doi:10.1007/s00213-010-1978-5.PMC 2981731.PMID 20703449.
  10. ^Koike H, Iijima M, Chaki S (December 2011). "Involvement of the mammalian target of rapamycin signaling in the antidepressant-like effect of group II metabotropic glutamate receptor antagonists".Neuropharmacology.61 (8):1419–23.doi:10.1016/j.neuropharm.2011.08.034.PMID 21903115.S2CID 23923192.
Group I
mGluR1Tooltip Metabotropic glutamate receptor 1
mGluR5Tooltip Metabotropic glutamate receptor 5
Group II
mGluR2Tooltip Metabotropic glutamate receptor 2
mGluR3Tooltip Metabotropic glutamate receptor 3
Group III
mGluR4Tooltip Metabotropic glutamate receptor 4
mGluR6Tooltip Metabotropic glutamate receptor 6
mGluR7Tooltip Metabotropic glutamate receptor 7
mGluR8Tooltip Metabotropic glutamate receptor 8
Retrieved from "https://en.wikipedia.org/w/index.php?title=MGS-0039&oldid=1134184419"
Categories:
Hidden categories:
[8]ページ先頭
©2009-2025 Movatter.jp